LipTide-ECP-102

N/A

Report date: 2025/10/28 17:33:48
NME

Base Information

Drug NameLipTide-ECP-102
Drug Alias NameUbiquitin ligase inhibitor (Nanogenics)ECP-102Ryboquin ECP-102
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUbiquitin-protein ligases inhibitors
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRyboquin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRyboquin Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A